Overhyped. Of all the words critics have levied against the cannabis industry, this is among the most common. And if we were having this conversation two years ago, we’d agree – to an extent. But as soon as the marijuana sector sorts out its issues, it’ll go on a bull run again. And given recent developments in the industry, we expect this will happen sooner rather than later.
But let’s be clear – if you want to cash in on the coming price run-up, you’ve got to get in on the ground floor. That doesn’t mean getting in when Jim Cramer is screaming about cannabis – it means taking a chance when everything is awful. Like right now.
Are you currently in a position where you can take a chance? If so, we know of three cannabis stocks in the OTC markets that may go up significantly soon. So, let’s cut the chit-chat and jump right into it.
Kaival Brands (OTCMKTS: KAVL)
When most people think of cannabis consumption, they envision hand-rolled joints. Many traditional smokers like it that way, but others don’t. Consumers in the latter group either find the rolling process to be too cumbersome, or they’re concerned about the health implications of inhaling unfiltered smoke.
So instead, these folks prefer to vape their cannabis. However, there’s another problem – buying and maintaining a vaping device can be a bit of a pain. To address this, Kaival Brands has unveiled the BIDI stick, a premium single-use vaping device. Through this device, buyers enjoy a better smoking experience, all without the hassle of having to care for their own e-cigarette.
So far, they’ve experienced significant success selling BIDIs in Florida and on authorized websites. But with 16 legal recreational cannabis markets in America – and new ones opening up regularly – there is significant potential for growth.
Right now, KAVL is hanging around in the 1.00 – 1.20 band after surging above 4.00 earlier in the year. Recent modest increases may signal a breakout soon. If the company reports positive earnings news in the short-term, investors could bag a decent profit.
Green Globe International (OTCMKTS: GGII)
Ditching tobacco cigarettes is tough. If you don’t believe that, ask any smoker – most have tried to quit at one point or another. Will power by itself doesn’t usually work – often, you’ll need to create a replacement behavior that supplants the initial habit.
Increasingly, quitters are replacing their tobacco habit with hemp. Hemp cigarettes lack nicotine and the witch’s brew of chemicals that one finds in conventional cigs. Further, these products are rich in CBD, without the THC commonly found in cannabis joints.
Numerous companies have found success marketing this product to smokers – Green Globe International is among them. Now, if you’ve done your research (and you should be), this may confuse you, as Google describes GGII as being in the sustainable travel & tourism business. But earlier in 2021, Hempacco, a San Diego-based manufacturer of hemp cigarettes, bought a controlling interest in GGII.
What does Hempacco do? This firm, as stated above, is in the hempettes business. At the moment, they offer consumers a selection of CBD, CBG, and hemp cigarettes.
By the time they’re featured, many OTC stocks have already popped. But not GGII – this firm is still on the ground floor, as it closed just above 0.07 at press time. So if you have some spare capital lying around, this might be an attractive way to invest in a potential trend – before it happens.
Want to learn more about GGII? Read about MJWL stock over at InsiderFinancial.com.
Trulieve Cannabis (OTCMKTS:TCNNF)
These days, the cannabis industry is moving pretty fast. One week, Trulieve Cannabis was a big deal in Florida. The next, it had become the largest marijuana company (by revenue) in the entire United States.
How did they make this monstrous shift? By acquiring Harvest Health and Recreation, an Arizona-based cannabis firm, for 2.1 billion USD. That’s a lot of cash, considering that the industry is still in its infancy.
Profitability is another area where Trulieve has surprised investors. For years, a lack of profitability has dogged the entire cannabis industry – especially in Canada. When you look at the dismal performances of giants like Canopy Growth or Tilray, it doesn’t exactly inspire confidence.
But this reality makes Trulieve stand out more than it already has. In Q1 2021, TCNNF logged its 13th consecutive profitable quarter – that’s impressive.
With a track record like this, this OTC stock is rather pricey. Recently, TCNNF retraced to below 40.00 after surging over 50.00 earlier this year. So if you’re looking for a cannabis stock that has blue-chip potential someday, Trulieve might be worth a buy.
Cannabis is Poised for a Post-Bubble Rally
Over the past few years, the cannabis sector has struggled mightily. But don’t give up on this industry’s most solid players – through it all, they’ve remained committed to coming out of the bust as market leaders.
Cannabis is trending towards alcohol’s levels of acceptance. In a world that’s getting crazier all the time, we do not doubt that this sector will become intensely profitable.